Episode Details

Back to Episodes

Two New Buys in the Portfolio, ASML's Recent Nosedive, and an Overvalued AI Stock.

Season 1 Episode 5 Published 1 year, 6 months ago
Description

Eric Bleeker and David Hanson address whether ASML is a "Buy" after its recent pullback, discuss the large-cap tech stock most likely to disappoint, break down the implications of using nuclear to power AI, and share the details of Eric's latest buys in the AI portfolio.

To follow along with the portfolio in real-time, follow Eric and 24/7 Wall Street on X.

Visit 24/7 Wall St. for all your market and investing news.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us